Lee Starker
Surgical Oncology · Morristown, NJNPI 1710161807
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 132 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 40 manufacturers, the largest accounting for just 10.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $573 and has fallen 50.8% since, to $282 in 2025.
Across 132 payments — averaging $16.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mirati Therapeutics, Inc.$226
- Seagen Inc.$204
- Novartis$150
- Daiichi Sankyo Inc.$130
- Pharmacosmos Therapeutics Inc.$109
- Incyte Corporation$102
- plus $1K from 34 others
What the payments were for
- Food & beverage$2,232100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mirati Therapeutics, Inc. | 14 | $226 |
| Seagen Inc. | 13 | $204 |
| Novartis | 10 | $150 |
| Daiichi Sankyo Inc. | 8 | $130 |
| Pharmacosmos Therapeutics Inc. | 1 | $109 |
| Incyte Corporation | 7 | $102 |
| Karyopharm Therapeutics Inc. | 6 | $94 |
| Johnson & Johnson(2 entities) | 6 | $88 |
| Astellas Pharma US Inc | 5 | $79 |
| Sanofi | 5 | $77 |
| Merck | 5 | $76 |
| Amgen | 5 | $76 |
| GSK | 4 | $68 |
| AstraZeneca | 4 | $68 |
| Jazz Pharmaceuticals Inc. | 4 | $67 |
| Regeneron Healthcare Solutions, Inc. | 4 | $60 |
| Kerecis Limited | 1 | $59 |
| E.r. Squibb & Sons, L.L.C. | 4 | $59 |
| Eisai Inc. | 3 | $49 |
| Medtronic | 1 | $40 |
| AbbVie | 2 | $31 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $30 |
| Foundation Medicine, Inc. | 1 | $28 |
| Caris MPI, Inc. | 1 | $19 |
| Cumberland Pharmaceuticals, Inc. | 1 | $19 |
| Angiodynamics, Inc. | 1 | $19 |
| Braintree Laboratories, Inc. | 1 | $18 |
| Bayer | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Galvanize Therapeutics, Inc | 1 | $16 |
| W. L. Gore & Associates, Inc. | 1 | $15 |
| Taiho Oncology, Inc. | 1 | $15 |
| EUSA Pharma (US) LLC | 1 | $14 |
| Lexicon Pharmaceuticals, Inc. | 1 | $14 |
| Advanced Accelerator Applications | 1 | $14 |
| Exelixis Inc. | 1 | $14 |
| Genentech USA, Inc. | 1 | $13 |
| Lilly USA, LLC | 1 | $13 |
| Tersera Therapeutics LLC | 1 | $13 |
| Bristol Myers Squibb | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Monoferric$109
How this compares
$2,232 in reported general payments places this provider in the 65th percentile of 59 surgical oncology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgical oncology in Morristown
- Lawrence HarrisonMorristown$2K
- Thangamani SeenivasanSomerville$22K
- John CunninghamBerkeley Heights$20K
- Manpreet KohliLong Branch$20K
- Haejin InNew Brunswick$12K
- Anjeanette BrownCape May Court House$11K
- Marc FromerBrick$9K
- Russell LanganLivingston$9K
- Elsa PichardoPlainsboro$8K
- Denise Johnson MillerNeptune$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.